Nicolas Sayegh

21PUBLICATIONS
50CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Rural and remote health servicesPlanning and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Jun 16, 2025
Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer.

Chadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay

|Jan 30, 2025
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy.

Georges Gebrael, Nicolas Sayegh, Chadi Hage Chehade

|Jan 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.

Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh

|May 23, 2024
Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.

Vinay Mathew Thomas, Beverly Chigarira, Georges Gebrael

|Apr 01, 2024
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.

Georges Gebrael, Chadi Hage Chehade, Nicolas Sayegh

Pageof 4

Frequent Collaborators

15 joint publications

Neeraj Agarwal

12 joint publications

Umang Swami

6 joint publications

Georges Gebrael

4 joint publications

Chadi Hage Chehade